对间变性淋巴瘤激酶基因融合变异的非小细胞肺癌患者的治疗策略(5)
[16] Peled N, Palmer G, Hirsch FR, et al. Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer [J]. J Thorac Oncol, 2012, 7(9): e14-e16.[17] Teixido C, Karachaliou N ......
您现在查看是摘要页,全文长 2584 字符。